A boost for CAR T cell therapy.

Nature materials · 1 Nov 2026 · Journal Article

Fitzgerald, Padilla + 1 more

The abstract is read at the publisher; the summary is JClub's.

There's no AI summary of this paper here yet.

Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.

An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation.
Nature materials · 1 Nov 2026 · Journal Article
AI summary · may contain errors
RT-modified oligoethylenimine-based lipid nanoparticles (ERTLNPs) enable ligand-free in vivo mRNA transfection in the spleen and intrinsically activate T cells.
- Open access
- 5 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42587055
Open in JClub

Journals this month

bioRxiv6521
medRxiv1773
PNAS578
JAMA362
Sci Adv338
Cell Rep278
BMJ218
Nat Commun190
Environ Res184
Nucleic Acids Res175
Plant Cell Environ175
NEJM146
Science143
Lancet132
Circulation129
Curr Biol126
Nature122
J Exp Bot114

All journals →

Topics moving, week to 11 Nov 2026

Single-cell and spatial transcriptomics13
CAR-T cell therapy research7
Genomics and Chromatin Dynamics6
CRISPR and Genetic Engineering6
Antibiotic Resistance in Bacteria6
Gut microbiota and health6
Inflammatory Bowel Disease6
Pancreatic and Hepatic Oncology Research5
Lipoproteins and Cardiovascular Health5
Genomics and Phylogenetic Studies4

All topics →

By field

General Science & Medicine14
Clinical Medicine10
Cell & Molecular Biology17
Immunology & Inflammation4
Neuroscience2
Genomics & Bioinformatics20
Microbiology & Mycology22
Oncology5
Protected Cropping & Horticultural Science4
Plant Physiology & Photobiology7
Student Research1

All journals by field →

A boost for CAR T cell therapy.

Related in JClub

An inherent T cell-activating mRNA delivery carrier for in vivo CAR T generation.

Browse JClub